TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Eterna Therapeutics ( (ERNA) ) is now available.
On June 12, 2025, Ernexa Therapeutics Inc. implemented a reverse stock split of its common stock at a ratio of 1-for-15 by filing a certificate of amendment with the Secretary of State of Delaware. This corporate action is likely aimed at consolidating shares to potentially enhance the company’s stock price and improve its market perception.
More about Eterna Therapeutics
Average Trading Volume: 360,017
Technical Sentiment Signal: Strong Sell
Current Market Cap: $9.67M
For a thorough assessment of ERNA stock, go to TipRanks’ Stock Analysis page.